tiprankstipranks
Trending News
More News >
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market
Advertisement

Huakang Biomedical Holdings Company Limited (8622) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

8622 Financial Forecast

8622 Earnings Forecast

The previous quarter’s earnings for 8622 were >-HK$0.01.
The previous quarter’s earnings for 8622 were >-HK$0.01.

8622 Sales Forecast

The previous quarter’s earnings for 8622 were HK$13.24M.
The previous quarter’s earnings for 8622 were HK$13.24M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on HK:8622
TR | OpenAI - 4o
TR | OpenAI - 4o
HK$0.5
Hold
25.00%
Upside
Reiterated
07/30/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on HK:8622
TR | OpenAI - 4o
TR | OpenAI - 4o
HK$0.5
Hold
25.00%
Upside
Reiterated
07/30/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

8622 Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Strong Buy
0
0
Buy
0
0
Hold
1
6
Sell
0
0
Strong Sell
0
0
total
1
6
In the current month, 8622 has received 0 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 8622 average Analyst price target in the past 3 months is 0.50.
Each month's total comprises the sum of three months' worth of ratings.

8622 Stock Forecast FAQ

What is HK:8622’s average 12-month price target, according to analysts?
Based on analyst ratings, Huakang Biomedical Holdings Company Limited’s 12-month average price target is 0.50.
    What is HK:8622’s upside potential, based on the analysts’ average price target?
    Huakang Biomedical Holdings Company Limited has 25.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Huakang Biomedical Holdings Company Limited a Buy, Sell or Hold?
          Huakang Biomedical Holdings Company Limited has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Huakang Biomedical Holdings Company Limited’s share price target?
            The average share price target for Huakang Biomedical Holdings Company Limited is 0.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$0.50 ,and the lowest forecast is HK$0.50. The average share price target represents 25.00% Increase from the current price of HK$0.4.
              What do analysts say about Huakang Biomedical Holdings Company Limited?
              Huakang Biomedical Holdings Company Limited’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Huakang Biomedical Holdings Company Limited?
                To buy shares of HK:8622, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis